methandrostenolone has been researched along with warfarin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Dresdale, FC; Hayes, JC | 1 |
| Kekki, M; Myllylä, G; Pyörälä, K | 1 |
| KEKKI, M; PYOERAELAE, K | 1 |
1 trial(s) available for methandrostenolone and warfarin
| Article | Year |
|---|---|
Metabolism of warfarin during methandrostenolone treatment.
Topics: Adult; Blood; Clinical Trials as Topic; Factor VII; Humans; In Vitro Techniques; Methandrostenolone; Prothrombin; Warfarin | 1965 |
3 other study(ies) available for methandrostenolone and warfarin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Potential dangers in the combined use of methandrostenolone and sodium warfarin.
Topics: Aged; Drug Synergism; Female; Humans; Methandrostenolone; Prothrombin Time; Warfarin | 1967 |
DECREASED ANTICOAGULANT TOLERANCE DURING METHANDROSTENOLONE THERAPY.
Topics: Anabolic Agents; Anticoagulants; Blood Proteins; Coronary Disease; Humans; Liver Function Tests; Methandrostenolone; Steroids; Warfarin | 1963 |